276 related articles for article (PubMed ID: 34061228)
21. Effect of rutin against a mitochondrial toxin, 3-nitropropionicacid induced biochemical, behavioral and histological alterations-a pilot study on Huntington's disease model in rats.
Suganya SN; Sumathi T
Metab Brain Dis; 2017 Apr; 32(2):471-481. PubMed ID: 27928694
[TBL] [Abstract][Full Text] [Related]
22. Neuroprotective potency of mangiferin against 3-nitropropionic acid induced Huntington's disease-like symptoms in rats: possible antioxidant and anti-inflammatory mechanisms.
Lum PT; Sekar M; Seow LJ; Shaikh MF; Arulsamy A; Retinasamy T; Gan SH; Gnanaraj C; Esa NM; Ramachawolran G; Subramaniyan V; Chinni SV; Wu YS
Front Pharmacol; 2023; 14():1189957. PubMed ID: 37521470
[TBL] [Abstract][Full Text] [Related]
23. Protective effects of phosphodiesterase-1 (PDE1) and ATP sensitive potassium (KATP) channel modulators against 3-nitropropionic acid induced behavioral and biochemical toxicities in experimental Huntington׳s disease.
Gupta S; Sharma B
Eur J Pharmacol; 2014 Jun; 732():111-22. PubMed ID: 24690258
[TBL] [Abstract][Full Text] [Related]
24. Effects of an Angiotensin IV Analog on 3-Nitropropionic Acid-Induced Huntington's Disease-Like Symptoms in Rats.
Wells RG; Azzam AF; Hiller AL; Sardinia MF
J Huntingtons Dis; 2024; 13(1):55-66. PubMed ID: 38489193
[TBL] [Abstract][Full Text] [Related]
25. Agmatine mitigates behavioral abnormalities and neurochemical dysregulation associated with 3-Nitropropionic acid-induced Huntington's disease in rats.
Katariya R; Mishra K; Sammeta S; Umekar M; Kotagale N; Taksande B
Neurotoxicology; 2024 May; 102():12-28. PubMed ID: 38453033
[TBL] [Abstract][Full Text] [Related]
26. Peroxisome proliferator-activated receptor-α activation attenuates 3-nitropropionic acid induced behavioral and biochemical alterations in rats: possible neuroprotective mechanisms.
Bhateja DK; Dhull DK; Gill A; Sidhu A; Sharma S; Reddy BV; Padi SS
Eur J Pharmacol; 2012 Jan; 674(1):33-43. PubMed ID: 22056833
[TBL] [Abstract][Full Text] [Related]
27. Mitochondrial modulators improve lipid composition and attenuate memory deficits in experimental model of Huntington's disease.
Mehrotra A; Sood A; Sandhir R
Mol Cell Biochem; 2015 Dec; 410(1-2):281-92. PubMed ID: 26374445
[TBL] [Abstract][Full Text] [Related]
28. Effect of resveratrol on 3-nitropropionic acid-induced biochemical and behavioural changes: possible neuroprotective mechanisms.
Kumar P; Padi SS; Naidu PS; Kumar A
Behav Pharmacol; 2006 Sep; 17(5-6):485-92. PubMed ID: 16940769
[TBL] [Abstract][Full Text] [Related]
29. Quercetin supplementation is effective in improving mitochondrial dysfunctions induced by 3-nitropropionic acid: implications in Huntington's disease.
Sandhir R; Mehrotra A
Biochim Biophys Acta; 2013 Mar; 1832(3):421-30. PubMed ID: 23220257
[TBL] [Abstract][Full Text] [Related]
30. Involvement of mGlu5 receptor in 3-nitropropionic acid-induced oxidative stress in rat striatum.
Souza LC; Wilhelm EA; Bortolatto CF; Nogueira CW; Boeira SP; Jesse CR
Neurol Res; 2014 Sep; 36(9):833-40. PubMed ID: 24588139
[TBL] [Abstract][Full Text] [Related]
31. Lycopene prevents 3-nitropropionic acid-induced mitochondrial oxidative stress and dysfunctions in nervous system.
Sandhir R; Mehrotra A; Kamboj SS
Neurochem Int; 2010 Nov; 57(5):579-87. PubMed ID: 20643176
[TBL] [Abstract][Full Text] [Related]
32. Anti-inflammatory effects of ellagic acid and vanillic acid against quinolinic acid-induced rat model of Huntington's disease by targeting IKK-NF-κB pathway.
Bains M; Kaur J; Akhtar A; Kuhad A; Sah SP
Eur J Pharmacol; 2022 Nov; 934():175316. PubMed ID: 36209926
[TBL] [Abstract][Full Text] [Related]
33. Protective role of sertraline against 3-nitropropionic acid-induced cognitive dysfunction and redox ratio in striatum, cortex and hippocampus of rat brain.
Kumar P; Kumar A
Indian J Exp Biol; 2009 Sep; 47(9):715-22. PubMed ID: 19957883
[TBL] [Abstract][Full Text] [Related]
34. Organoselenium bis selenide attenuates 3-nitropropionic acid-induced neurotoxicity in rats.
Bortolatto CF; Jesse CR; Wilhelm EA; Chagas PM; Nogueira CW
Neurotox Res; 2013 Apr; 23(3):214-24. PubMed ID: 22739838
[TBL] [Abstract][Full Text] [Related]
35. Probucol modulates oxidative stress and excitotoxicity in Huntington's disease models in vitro.
Colle D; Hartwig JM; Soares FA; Farina M
Brain Res Bull; 2012 Mar; 87(4-5):397-405. PubMed ID: 22245028
[TBL] [Abstract][Full Text] [Related]
36. A Novel Pharmacological Protective Role for Safranal in an Animal Model of Huntington's Disease.
Fotoohi A; Moloudi MR; Hosseini S; Hassanzadeh K; Feligioni M; Izadpanah E
Neurochem Res; 2021 Jun; 46(6):1372-1379. PubMed ID: 33611726
[TBL] [Abstract][Full Text] [Related]
37. Lycopene modulates nitric oxide pathways against 3-nitropropionic acid-induced neurotoxicity.
Kumar P; Kalonia H; Kumar A
Life Sci; 2009 Nov; 85(19-20):711-8. PubMed ID: 19822156
[TBL] [Abstract][Full Text] [Related]
38. Novel protective mechanisms of antidepressants against 3-nitropropionic acid induced Huntington's-like symptoms: a comparative study.
Kumar P; Kalonia H; Kumar A
J Psychopharmacol; 2011 Oct; 25(10):1399-411. PubMed ID: 20305041
[TBL] [Abstract][Full Text] [Related]
39. Thymoquinone loaded solid lipid nanoparticles counteracts 3-Nitropropionic acid induced motor impairments and neuroinflammation in rat model of Huntington's disease.
Ramachandran S; Thangarajan S
Metab Brain Dis; 2018 Oct; 33(5):1459-1470. PubMed ID: 29855977
[TBL] [Abstract][Full Text] [Related]
40. Mitochondrial dysfunction, oxidative stress, ER stress and mitochondria-ER crosstalk alterations in a chemical rat model of Huntington's disease: Potential benefits of bezafibrate.
Brondani M; Roginski AC; Ribeiro RT; de Medeiros MP; Hoffmann CIH; Wajner M; Leipnitz G; Seminotti B
Toxicol Lett; 2023 May; 381():48-59. PubMed ID: 37116597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
